Results 161 to 170 of about 3,031,498 (306)

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Soft tissue disorders of the foot and ankle: The Achilles tendon and plantar fascia

Indian Journal of Rheumatology, 2014
Cathy A. Speed
doaj   +1 more source

Abstract Representation of Movement Parameters in Basal Ganglia Output. [PDF]

Adv Sci (Weinh)
Báez-Cordero AS, Ortega-Romero DI, Pérez-Díaz CI, Rueda-Orozco PE.   +3 more
europepmc   +1 more source

The Speed of Publication [PDF]

Journal of Proteome Research, 2018
openaire   +2 more sources

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Arthropod-Inspired Miniature Modular Vibration Direct-Drive Robot With Untethered Locomotion. [PDF]

Adv Sci (Weinh)
Zhang S, Liu Z, Liu Y, Wang D, Liu Y.
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Camera-GPS Sensor Fusion for Kinematic Characterization, Microsimulation Validation, and Macroscopic Capacity Modeling of Traffic-Calming Corridors. [PDF]

Sensors (Basel)
Chimba D, Mariki W, Shrestha S, Yeboah A.   +3 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

IMU-Based Analysis of Task-Dependent Associations Between Anticipatory Postural Adjustments and Gait Speed Under Dual-Task Conditions. [PDF]

Sensors (Basel)
Sakaki Y, Akagi H, Kawata A, Sawamura D, Mani H, Hasegawa N.   +5 more
europepmc   +1 more source